Clinical Trial Update: A Phase 3 Study of Zalunfiban in Subjects With ST-elevation MI [Phase 3]

View source ↗

Summary

A Phase 3 trial of Zalunfiban in patients with ST-elevation myocardial infarction is listed as active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-elevation Myocardial Infarction

Drugs mentioned

• Zalunfiban (Zalunfiban)

Snippet

Sponsor: CeleCor Therapeutics | Conditions: ST-elevation Myocardial Infarction (STEMI) | Phase 3 | Status: ACTIVE_NOT_RECRUITING